Cargando…
National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation
Prominent reports have assessed the challenges to antibiotic innovation and recommended implementing “pull” incentives, i.e., mechanisms that give increased and predictable revenues for important, marketed antibiotics. We set out to understand countries’ perceptions of these recommendations, through...
Autores principales: | Årdal, Christine, Lacotte, Yohann, Edwards, Suzanne, Ploy, Marie-Cécile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234425/ https://www.ncbi.nlm.nih.gov/pubmed/34205554 http://dx.doi.org/10.3390/antibiotics10060749 |
Ejemplares similares
-
Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe
por: Årdal, Christine, et al.
Publicado: (2020) -
Infection prevention and control research priorities: what do we need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative literature review and survey analysis
por: Lacotte, Yohann, et al.
Publicado: (2020) -
Supply chain transparency and the availability of essential medicines
por: Årdal, Christine, et al.
Publicado: (2021) -
BARRIERS AND FACILITATORS TO IMPLEMENTING THE BALANCING INCENTIVE PROGRAM (BIP)
por: Beauregard, Lisa, et al.
Publicado: (2019) -
Linking Sustainable Use Policies to Novel Economic Incentives to Stimulate Antibiotic Research and Development
por: Theuretzbacher, Ursula, et al.
Publicado: (2017)